Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML

Clinical trial NCT03922100 · TERMINATED

Trial details

NCT number: NCT03922100
Sponsor: Nerviano Medical Sciences
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Chronic Myelomonocytic Leukemia (CMML)

Start date: 2019-04-03
Primary completion: 2024-08-29
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.